HCID 385601, 화합물 → HCID 18174628, 화합물
반응식
C(O[C:9]([NH:11][C:12]1[CH:13]=[C:14]([CH:16]=[CH:17][CH:18]=1)[NH2:15])=[O:10])C1C=CC=CC=1.[C:19]([C:23]1[CH:28]=[CH:27][C:26]([C:29]2[O:34]C(=O)[C:32]3[CH:36]=[CH:37][CH:38]=[CH:39][C:31]=3[N:30]=2)=[CH:25][CH:24]=1)([CH3:22])([CH3:21])[CH3:20]>>[NH2:15][C:14]1[CH:13]=[C:12]([NH:11][C:9](=[O:10])[C:32]2[CH:36]=[CH:37][CH:38]=[CH:39][C:31]=2[NH:30][C:29](=[O:34])[C:26]2[CH:25]=[CH:24][C:23]([C:19]([CH3:21])([CH3:20])[CH3:22])=[CH:28][CH:27]=2)[CH:18]=[CH:17][CH:16]=1참가 물질
3
실험 절차
By methods substantially equivalent to those described in Example 96, the title compound (40 mg, 9% for two steps) was prepared from m-(benzyloxycarbonylamino)aniline 1.5 mmol) and 2-(4-tert-butylphenyl)-4H-3,1-benzoxazin-4-one (1.5 mmol).
출처 및 근거
- ORD 기록
- ord-0d4269360b94417d87828f276f717309
- 출처 데이터셋
- uspto-grants-2003_08
- 특허 번호
- US06605626B2
반응 노트
불러오는 중…